Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price ▼ | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Incyte Corp. | 14 | 2 | 2 | 0 | €61.50 | €76.76 | 24.816% |
| Regeneron Pharmaceuticals Inc. | 53 | 1 | 6 | 0 | €922.40 | €1,080.6 | 17.152% |
| Exact Sciences | 20 | 0 | 4 | 0 | €62.28 | €75.89 | 21.855% |
| Johnson & Johnson | 41 | 1 | 6 | 0 | €146.04 | €192.63 | 31.902% |
| Roche Holding AG ADR | 4 | 3 | 1 | 1 | €34.43 | €38.00 | 10.366% |
| Novo Nordisk A/S ADR | 25 | 1 | 4 | 0 | €105.00 | €144.48 | 37.600% |
| Elanco Animal Health Inc. | 10 | 2 | 2 | 0 | €13.11 | €17.10 | 30.470% |
| Teva Pharmaceutical Industries Ltd ADR | 20 | 0 | 1 | 0 | €15.95 | €19.37 | 21.445% |
| Amgen Inc. | 29 | 1 | 3 | 1 | €291.20 | €304.82 | 4.677% |
| Sanofi S.A. | 4 | 0 | 0 | 0 | €100.90 | €109.00 | 8.028% |
| Pfizer Inc. | 29 | 4 | 5 | 0 | €26.04 | €40.64 | 56.078% |
| Gilead Sciences Inc | 11 | 0 | 1 | 0 | €77.06 | €85.74 | 11.260% |
| AbbVie Inc. | 33 | 0 | 0 | 0 | €176.98 | €181.45 | 2.524% |
| Merck KGaA | 8 | 1 | 4 | 0 | €155.30 | €172.00 | 10.753% |
| Novartis AG ADR | 4 | 0 | 1 | 0 | €104.00 | €112.40 | 8.074% |
| Bristol-Myers Squibb | 5 | 3 | 0 | 0 | €49.16 | €55.50 | 12.897% |
| Eli Lilly Corp. | 73 | 0 | 10 | 0 | €807.70 | €832.87 | 3.116% |
| Sanofi S.A. ADR | 12 | 0 | 5 | 0 | €51.00 | €55.25 | 8.341% |
| AstraZeneca plc | 3 | 0 | 1 | 0 | €141.00 | €157.75 | 11.879% |
| Bayer AG | 16 | 4 | 4 | 3 | €29.84 | €45.00 | 50.804% |
| Merck & Co. Inc. | 31 | 1 | 2 | 0 | €100.00 | €126.98 | 26.981% |
| Novo Nordisk A/S | 4 | 0 | 0 | 0 | €185.00 | €195.00 | 5.405% |
| Abbott Laboratories | 22 | 0 | 3 | 0 | €102.60 | €116.48 | 13.529% |
| UCB S.A. | 1 | 0 | 1 | 0 | €166.55 | €210.00 | 26.088% |
| Vertex Pharmaceuticals Inc. | 57 | 2 | 1 | 0 | €414.75 | €440.14 | 6.121% |